Search

Your search keyword '"Allen, Larry A."' showing total 2,373 results
Start Over Author "Allen, Larry A."
2,373 results on '"Allen, Larry A."'

155. 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways

Author

Yancy, Clyde W., Januzzi, James L., Jr., Allen, Larry A., Butler, Javed, Davis, Leslie L., Fonarow, Gregg C., Ibrahim, Nasrien E., Jessup, Mariell, Lindenfeld, JoAnn, Maddox, Thomas M., Masoudi, Frederick A., Motiwala, Shweta R., Patterson, J. Herbert, Walsh, Mary Norine, and Wasserman, Alan

Published
2018
Full Text
View/download PDF

156. Behavior of Young-of-the-Year Giant Sea Bass, Stereolepis gigas, off the Sandy Beaches of Southern California

Author

Benseman, Stephanie A., Couffer, Michael C., and Allen, Larry G.

Subjects
Perciformes -- Behavior, Animal young -- Behavior, Science and technology
Abstract

Abstract.--We made extensive observations in the shallows off sandy beaches along the southern California coastline from 2013-2018 using SCUBA. The common diurnal behavior of young-of-the-year (YOY) of giant sea bass, [...]

Published
2019

166. Clinician challenges to evidence‐based prescribing for heart failure and reduced ejection fraction: A qualitative evaluation

Author

Trinkley, Katy E., primary, Dafoe, Ashley, additional, Malone, Daniel C., additional, Allen, Larry A., additional, Huebschmann, Amy, additional, Khazanie, Prateeti, additional, Lunowa, Cali, additional, Matlock, Daniel C., additional, Suresh, Krithika, additional, Rosenberg, Michael A., additional, Swat, Stanley A., additional, Sosa, Aracely, additional, and Morris, Megan A., additional

Published
2023
Full Text
View/download PDF

168. Quality of Care and Clinical Outcomes for Patients With Heart Failure at Hospitals Caring for a High Proportion of Black Adults

Author

Diamond, Jamie, primary, Ayodele, Iyanuoluwa, additional, Fonarow, Gregg C., additional, Joynt-Maddox, Karen E., additional, Yeh, Robert W., additional, Hammond, Gmerice, additional, Allen, Larry A., additional, Greene, Stephen J., additional, Chiswell, Karen, additional, DeVore, Adam D., additional, Yancy, Clyde, additional, and Wadhera, Rishi K., additional

Published
2023
Full Text
View/download PDF

169. A novel approach for assessing bias during team-based clinical decision-making

Author

Pool, Natalie, primary, Hebdon, Megan, additional, de Groot, Esther, additional, Yee, Ryan, additional, Herrera-Theut, Kathryn, additional, Yee, Erika, additional, Allen, Larry A., additional, Hasan, Ayesha, additional, Lindenfeld, JoAnn, additional, Calhoun, Elizabeth, additional, Carnes, Molly, additional, Sweitzer, Nancy K., additional, and Breathett, Khadijah, additional

Published
2023
Full Text
View/download PDF

172. Abstract 13165: Self-Reported Social Functioning is Responsive to Change in Functional Class in Patients With a Left Ventricular Assist Device: Findings From the Mechanical Circulatory Support Measures of Adjustment and Quality of Life Study

Author

Hahn, Elizabeth A, Cummings, Peter D, Wortman, Katy, Lindenfeld, Joann, Teuteberg, Jeffrey, Kiernan, Michael S, Allen, Larry A, McIlvennan, Colleen K, Lee, Christopher S, Denfeld, Quin E, Klein, Liviu, Beiser, David, Murks, Catherine M, Rich, Jonathan D, Pham, Duc T, Yancy, Clyde W, Cella, David, Walsh, Mary N, Ruo, Bernice, Buono, Sarah K, and Grady, Kathleen L

Published
2020
Full Text
View/download PDF

178. Evaluation of Loop Diuretic Dosing Following Sodium-Glucose Cotransporter 2 Inhibitor Initiation in Patients With Heart Failure.

Author

Trudeau, Brooke M., Allen, Larry A., Billups, Sarah J., Saseen, Joseph J., and Pearson, Scott M.

Subjects
*DIURETICS, *TIME, *RETROSPECTIVE studies, *TYPE 2 diabetes, *PHARMACEUTICAL arithmetic, *TREATMENT effectiveness, *DESCRIPTIVE statistics, *DRUG therapy, *DOSE-effect relationship in pharmacology, *SODIUM-glucose cotransporter 2 inhibitors, *HYPOTENSION, *HEART failure, *DISEASE complications
Abstract

Introduction: Sodium-glucose cotransporter 2 inhibitors (SGLT2is) have demonstrated cardiovascular benefits in patients with heart failure, many of which take loop diuretics. There are no evidence-based recommendations identifying which patients may require loop diuretic dose decreases or how to adjust loop diuretic doses when SGLT2is are initiated. Objectives: The main objective of this study was to investigate the frequency and degree of adjustments in loop diuretic doses after SGLT2i initiation in patients with heart failure. Methods: In this retrospective evaluation, patients seen in the UCHealth system with a diagnosis of heart failure who were prescribed a loop diuretic before initiation of SGLT2i were identified. We described loop diuretic dose changes at the time of SGLT2i initiation, at 6 months after initiation, and at 1 year after initiation. We also described de-escalation of maintenance medications that can contribute to hypotension at these time points. Data were evaluated using descriptive statistics. Results: A total of 100 patients were included. Loop diuretic dose was reduced empirically upon SGLT2i initiation in 2.0% of patients. Reduction of loop diuretic dose within the first 6 months of starting an SGLT2i occurred in 8.0% of patients. From baseline to 12 months after starting SGLT2i therapy, 14.0% of patients had loop diuretic dose reduction. Conclusions: Most of our patients with HF did not have change in loop diuretic dose after initiation of an SGLT2i. In patients who did have loop diuretic dose reduction, most occurred within 6 months after starting SGLT2i therapy rather than empirically at time of initiation. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

184. Outcomes of Cardiac Catheterization in Patients With Atrial Fibrillation on Anticoagulation in Contemporary in Practice: An Analysis of the ORBIT II Registry

Author

Sherwood, Matthew W., Piccini, Jonathan P., Holmes, DaJuanicia N., Pieper, Karen S., Steinberg, Benjamin A., Fonarow, Gregg C., Allen, Larry A., Naccarelli, Gerald V., Kowey, Peter R., Gersh, Bernard J., Mahaffey, Kenneth W., Singer, Daniel E., Ansell, Jack E., Freeman, James V., Chan, Paul S., Reiffel, James A., Blanco, Rosalia, Peterson, Eric D., and Rao, Sunil V.

Published
2020
Full Text
View/download PDF

192. Group Dynamics and Allocation of Advanced Heart Failure Therapies—Heart Transplants and Ventricular Assist Devices—By Gender, Racial, and Ethnic Group

Author

Breathett, Khadijah, primary, Yee, Ryan, additional, Pool, Natalie, additional, Thomas Hebdon, Megan C., additional, Knapp, Shannon M., additional, Herrera‐Theut, Kathryn, additional, de Groot, Esther, additional, Yee, Erika, additional, Allen, Larry A., additional, Hasan, Ayesha, additional, Lindenfeld, JoAnn, additional, Calhoun, Elizabeth, additional, Carnes, Molly, additional, and Sweitzer, Nancy K., additional

Published
2023
Full Text
View/download PDF

194. APPLICABILITY OF THE GALACTIC-HF TRIAL AND OMECAMTIV MECARBIL TO PATIENTS HOSPITALIZED FOR HEART FAILURE IN THE UNITED STATES: FROM THE GWTG-HF REGISTRY

Author

Harrington, Josephine, primary, Sun, Jie, additional, Fonarow, Gregg C., additional, Heitner, Stephen B., additional, Divanji, Punag, additional, Alhanti, Brooke, additional, Allen, Larry A., additional, Yancy, Clyde W., additional, Albert, Nancy M., additional, DeVore, Adam, additional, Felker, G. Michael, additional, and Greene, Stephen, additional

Published
2023
Full Text
View/download PDF

195. CHARACTERIZING THE DIGITAL DIVIDE & ACCESS TO MOBILE HEALTH INTERVENTIONS IN HEART FAILURE: INSIGHTS FROM THE CONNECT-HF MHEALTH SUBSTUDY

Author

Diamond, Jamie Elizabeth, primary, Kaltenbach, Lisa, additional, Granger, Bradi, additional, Fonarow, Gregg C., additional, Al-Khalidi, Hussein, additional, Albert, Nancy M., additional, Butler, Javed, additional, Allen, Larry A., additional, Lanfear, David E., additional, Thibodeau, Jennifer T., additional, Granger, Christopher B., additional, Hernandez, Adrian F., additional, and DeVore, Adam, additional

Published
2023
Full Text
View/download PDF

196. ADJUSTMENT OF GUIDELINE-DIRECTED MEDICAL THERAPY ONE YEAR POST-HEART FAILURE HOSPITALIZATION FALLS SHORT: INSIGHTS FROM THE CONNECT-HF TRIAL

Author

Chapman, Brittany, primary, Kaltenbach, Lisa, additional, Granger, Bradi, additional, Allen, Larry A., additional, Albert, Nancy M., additional, Al-Khalidi, Hussein, additional, Granger, Christopher B., additional, Lanfear, David E., additional, Thibodeau, Jennifer T., additional, Oliver-McNeil, Sandra M., additional, Butler, Javed, additional, Felker, G. Michael, additional, Pina, Ileana L., additional, Fonarow, Gregg C., additional, Hernandez, Adrian F., additional, and DeVore, Adam, additional

Published
2023
Full Text
View/download PDF

199. Palliative care in heart failure guidelines: A comparison of the 2021 ESC and the 2022 AHA/ACC/HFSA guidelines on heart failure

Author

Blum, Moritz, Goldstein, Nathan E., Jaarsma, Tiny, Allen, Larry A., Gelfman, Laura P., Blum, Moritz, Goldstein, Nathan E., Jaarsma, Tiny, Allen, Larry A., and Gelfman, Laura P.

Abstract

The role of palliative care for patients with heart failure (HF) is discussed in both most recent HF guidelines, the 2021 ESC guideline and the 2022 AHA/ACC/HFSA guideline. This review compares the definitions, concepts and specific recommendations regarding palliative care for patients with HF in these two guidelines. Both HF guidelines define palliative care as a multidisciplinary approach aimed at alleviating physical, psychological and spiritual distress of patients and caregivers. Both agree emphatically on the importance of palliative care across all stages of HF with integration early in the illness trajectory. Also, the guidelines concur that palliative care should include symptom management, communication about prognosis and life-sustaining therapies, as well as advance care planning. Despite this consensus, only the AHA/ACC/HFSA guideline gives official recommendations on the provision of palliative care. Moreover, the AHA/ACC/HFSA guideline advocates for a needs-based approach to palliative care allocation while the ESC guideline ties palliative care closely to advanced HF and end-of-life care. The ESC guideline highlights the need for regular symptom assessment and provides detailed guidance on symptom management. The AHA/ACC/HFSA guideline elaborates further on shared decision-making, caregiver and bereavement support, as well as hospice care, and distinguishes between primary palliative care (provided by all clinicians) and secondary (specialty-level) palliative care. Although there is strong agreement on the importance and components of palliative care for patients with HF, there are nuanced differences between the two HF guidelines. Most notably, only the AHA/ACC/HFSA guideline issues recommendations for the provision of palliative care.

Published
2023
Full Text
View/download PDF

200. Group Dynamics and Allocation of Advanced Heart Failure Therapies-Heart Transplants and Ventricular Assist Devices-By Gender, Racial, and Ethnic Group

Author

Huisartsopleiding, Breathett, Khadijah, Yee, Ryan, Pool, Natalie, Thomas Hebdon, Megan C, Knapp, Shannon M, Herrera-Theut, Kathryn, de Groot, Esther, Yee, Erika, Allen, Larry A, Hasan, Ayesha, Lindenfeld, JoAnn, Calhoun, Elizabeth, Carnes, Molly, Sweitzer, Nancy K, Huisartsopleiding, Breathett, Khadijah, Yee, Ryan, Pool, Natalie, Thomas Hebdon, Megan C, Knapp, Shannon M, Herrera-Theut, Kathryn, de Groot, Esther, Yee, Erika, Allen, Larry A, Hasan, Ayesha, Lindenfeld, JoAnn, Calhoun, Elizabeth, Carnes, Molly, and Sweitzer, Nancy K

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results